Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine
Conditions: Severe Preeclampsia Interventions: Drug: Labetalol; Drug: Nitroglycerine; Drug: Nifedipine Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
Conditions: Hypertensive Disorder of Pregnancy Interventions: Drug: NIFEdipine ER Sponsors: Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA)
DiscussionThis trial aims to address the uncertainty of which antihypertensive treatment is associated with optimal maternal and neonatal outcomes. The trial results are intended to provide definitive evidence to inform guidelines and linked, shared decision-making tools, thus influencing clinical practice.Trial registrationEudraCT number: 2020 –003410-12, ISRCTN: 12,792,616 registered on 18 November 2020. (Source: Trials)
Source: Trials - September 12, 2023 Category: Research Source Type: clinical trials
Treatment of Elevated Blood Pressures in Early Pregnancy
Conditions: Elevated Blood Pressure; Pregnancy Induced Hypertension Interventions: Drug: Nifedipine; Drug: Labetalol Sponsor: Marshall University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2023 Category: Research Source Type: clinical trials
